pharmafield logo - pharma news

Emma McConnell tells us how she has built a successful career which helps to...

  Emma McConnell, Scientific Director at Ashfield Healthcare Communications – part of UDG Healthcare plc – tells us how she has built a successful...
pharmafield logo - pharma news

How can you maximise your primary care investment when the focus is shifting to...

Read the full article and infographics here.    The market is changing... The landscape of pharma is clearly changing rapidly – the emergence of...
pharmafield logo - pharma news

Our way: Talent attraction specialist, Gemma Sawyer, reflects on a memorable 2016 for Novo...

    What makes Novo Nordisk different? Novo Nordisk is a unique company because we really care about our social, environmental and financial responsibility...
pharmafield logo - pharma news

Global talent VP, Erica Briody, looks back on a fascinating 12 months for QuintilesIMS

  Human league: Global talent VP, Erica Briody, looks back on a fascinating 12 months for QuintilesIMS   What is QuintilesIMS and what makes...
pharmafield logo - pharma news

It has to be you: Looking for that promotion? Striving for success? Want an...

  Who is going to gain recognition, reward and achievement? Can you really leave it to someone or something else? Employment has changed. The...
pharmafield logo - pharma news

Transformers: connection, capabilities and culture in modern pharma

  Dan Masquelier, Partner, Cormis Partnership, talks about the importance of connection, capabilities and culture in a modern pharma ecosystem.   What is Cormis...
pharmafield logo - pharma news

Andrew Waiton explains why good habits start from the inside

KIE to success   Key Opinion Leaders, Thought Leaders and Key External Experts (KEE) have – for years – led best practice and influenced...
pharmafield logo - pharma news

Training your Millennials: How to measure the training investment in your Generation Y employees.

Historically, the paradigm has been that, ‘of course’ organisations should provide training for their employees. It engenders loyalty, and it is the socially responsible...

Latest articles

People sitting around a desk with laptops and tablets to show Pharma drug approvals round-up: UK, Europe, US

What’s been authorised? UK, Europe, US drug approvals

Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
hands holding smart phones to show Digital interventions for behaviour change

Digital interventions for behaviour change

New NICE guidance looks at digital interventions for behaviour change and suggests that these interventions such as apps, wearable devices and online programmes and...
image of red and blue heart on purple background to show Acute aortic dissection is a 'ticking time bomb'

Acute aortic dissection is a ‘ticking time bomb’

Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...

Popular articles

People sitting around a desk with laptops and tablets to show Pharma drug approvals round-up: UK, Europe, US

What’s been authorised? UK, Europe, US drug approvals

Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
black and white photo of Craig Bradley to show Key publications to impact the UK access environment in 2020

Key publications to impact the UK access environment in 2020

Craig Bradley, Commercial Lead Rare GI at Takeda, PM Society Chair & PM Society Market Access Interest Group Lead, looks at key publications to...
image of lungs, the left lung is bordered by orange, the right by blue to show AstraZeneca's Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England

AstraZeneca’s Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England

The National Institute for Health and Care Excellence (NICE) has published final guidance that does not recommend AstraZeneca's Tagrisso▼ (osimertinib) for use within NHS...
Image of man and woman sat in waiting room holding their stomachs to show NICE rejects Janssen's Stelara for moderate to severe ulcerative colitis

NICE rejects Janssen’s Stelara for moderate to severe ulcerative colitis

The National Institute for Health and Care Excellence (NICE) has not recommended ustekinumab, Janssen's Stelara, for treating moderately to severely active ulcerative colitis in...
Illustration of people meeting at a table that looks like a pill to show Tiofarma admits illegal role in fludrocortisone anti-competitive agreement

Tiofarma admits illegal role in fludrocortisone anti-competitive agreement

Tiofarma has admitted that it took part in a fludrocortisone anti-competitive agreement that resulted in significant price hikes for the essential medicine. This means that...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription